--- title: Clarivius — Global Clinical Consultation Platform & Specialist Precedent Network tagline: The Pathway to Clinical Clarity / Vaše cesta ke klinickému vyřešení / Der Weg zur klinischen Klarheit url: https://clarivius.com/ updated: 2026-10-27 languages: [en, cs, de] data_residency: European Union (Frankfurt / Prague) compliance: GDPR Art. 6 & Art. 9 Compliant Dual-Track Architecture --- # Clarivius — The Pathway to Clinical Clarity > **Mission**: *"No complex case stays unprecedented simply because the right specialist is not here right now."* Clarivius is a **Global Clinical Consultation Platform and Specialist Precedent Network** connecting treating physicians (via **Clarivius Peer**) and patients (via **Clarivius Direct**) with verified sub-specialists worldwide who have documented hands-on clinical precedent resolving rare, complex, and unclassified medical conditions. --- ## 1. What Is Clarivius? Clarivius is built on a three-pillar architecture uniting an indexed precedent registry with two purpose-built consultation workflows: ### Pillar 1: Global Specialist Precedent Index An indexed intelligence network that catalogs medical sub-specialists by documented rare-case precedent, surgical series, advanced cross-sectional imaging protocols (e.g., 3T Pelvic MRI), and peer endorsements—not generic hospital titles. ### Pillar 2: Clarivius Peer (Doctor-to-Doctor) A zero-PII clinical consultation workflow for hospital physicians, multidisciplinary tumor/radiology boards, and surgical departments. Submit a structured 4-field clinical case (Age, Sex, BMI, Narrative) in 90 seconds and receive a signed peer consultation summary from an international colleague who has treated that exact presentation. ### Pillar 3: Clarivius Direct (Patient-to-Specialist) A consent-backed consultation service for patients with unresolved, chronic, or complex diagnoses. Upload complete clinical records and raw cross-sectional DICOM imaging (3T MRI, CT) under explicit GDPR Art. 6 and Art. 9 consent to receive an expert sub-specialist second opinion and a Treating-Physician Handover Brief for shared care. --- ## 2. How It Works ### Pathway A: Clarivius Peer (Doctor-to-Doctor Consultation) 1. **90-Second Structured Case Intake**: The treating doctor inputs only four clinical parameters (Age, Sex, BMI, de-identified Clinical Narrative). 2. **Zero-PII Compliance Gate**: Automated privacy filters verify that zero personal identifiers (names, dates of birth, national IDs) are present. 3. **Precedent & Endorsement Matching**: The matching engine ranks verified international sub-specialists by documented clinical similarity to that exact presentation. 4. **Collegial Exchange & Signed Summary**: The matched specialist reviews the case and returns a signed peer consultation summary. Full clinical responsibility remains with the treating physician. ### Pathway B: Clarivius Direct (Patient-to-Specialist Review) 1. **Consented Case & DICOM Intake**: Under granular GDPR informed consent, the patient uploads their medical history, lab reports, and full cross-sectional DICOM imaging (3T Pelvic MRI, CT) into an isolated European Union vault. 2. **Sub-Specialist Precedent Selection**: Clarivius matches the dossier to a verified international sub-specialist who has published on or operated on that specific anatomical condition. 3. **Independent Raw DICOM Review**: The sub-specialist inspects the uncompressed multi-planar imaging sequences to identify subtle anatomical communications often missed in routine cross-sectional reads. 4. **Written Specialist Report & Shared Care**: The patient receives a comprehensive written specialist consultation report plus a structured **Treating-Physician Handover Brief** to align local surgeons. --- ## 3. Founding Clinical Case Study: 18 Doctors, 18 Months Clarivius was founded after an 18-month diagnostic odyssey across 18 doctors and 5 medical specialties (General Surgery, Proctology, Urology, Radiology, Microbiology) resolving a unilateral Cowper's gland (*glandula bulbourethralis*) syringocele and perineal fistula: - **18 Doctors** consulted across regional and university hospitals. - **18 Months** from initial perineal mass to definitive surgical indication. - **5 Specialties** involved without reaching diagnostic synthesis. - **0 of 24 European Reference Networks** cover this accessory male reproductive gland pathology. - **< 72 Hours** target match time via the Clarivius Precedent Index to European centers with published bulbourethral series. ### Chronological Stages - **Stage 1 (Months 1–2)**: Initial perineal lump misdiagnosed as furuncle/abscess (ICD-10 L023) then benign neoplasm (ICD-10 D235). First MRI reports 47 mm transsphincteric perianal fistula opening at 1 o'clock. - **Stage 2 (Months 3–7)**: Proctological Fistula-tract Laser Closure (FiLaC). Distal skin tract sealed, but upstream gland untouched. At Month 7, high-pressure post-ejaculatory mucoprotein relapse occurs. - **Stage 3 (Months 8–11)**: Multi-departmental deadlock. Retrograde urethrography (UCG) is false-negative because intraluminal positive pressure compresses the oblique duct orifice shut like a one-way flap valve. - **Stage 4 (Months 11–12)**: High-resolution 3T Pelvic MRI (thin-slice T2 TSE and fat-suppressed STIR) directly visualizes a 12 × 8 mm cystic dilation in the right Cowper's gland in the deep perineal space with fistulous communication. - **Stage 5 (Months 13–18)**: Precedent matching identifies European centers experienced in endoscopic Holmium:YAG laser marsupialization and open transperineal bulbourethral excision. --- ## 4. Architectural & GDPR Data Isolation Matrix | Dimension | Clarivius Peer (Doctor-to-Doctor) | Clarivius Direct (Patient-to-Specialist) | | :--- | :--- | :--- | | **Legal Basis** | Anonymised health data (outside GDPR Art. 4(1); zero PII). | Explicit per-consultation informed consent (GDPR Art. 6 & 9). | | **Data Scope** | 4 fields: Age, Sex, BMI, de-identified narrative. | Full records, lab results, raw multi-planar DICOM imaging. | | **Storage Isolation**| Isolated database schema; no joins to identifiable tables. | Encrypted EU patient vault with dedicated KMS key hierarchy. | | **Deliverable** | Signed collegial peer consultation summary. | Written specialist opinion + Treating-Physician Handover Brief. | | **Clinical Lead** | 100% retained by local hospital treating physician. | Advisory specialist opinion; local hospital executes treatment. | | **Data Residency** | EU Regions exclusively (Frankfurt / Prague). | EU Regions exclusively (Frankfurt / Prague). | --- ## 5. Clinical Safety & Governance Safeguards - **Zero AI Diagnoses**: No software component or AI model generates medical diagnoses or replaces the treating doctor. - **Verified Human Specialists**: Every consultation summary is authored and signed by a verified medical sub-specialist. - **Strict Data Segregation**: Track A (anonymised peer consults) and Track B (identifiable patient dossiers) run on completely separate schemas, encryption keys, and role boundaries. - **EU Data Residency**: Hosted exclusively in the European Union (Frankfurt / Prague). --- ## 6. Access & Contact - **Platform Web**: https://clarivius.com - **Clinical Desk**: clinical@clarivius.com - **Data Protection Office**: dpo@clarivius.com - **Documentation**: - LLM Profile: https://clarivius.com/llms.txt - Unabridged Knowledge Base: https://clarivius.com/llms-full.txt - XML Sitemap: https://clarivius.com/sitemap.xml - Robots Policy: https://clarivius.com/robots.txt